Enliven Therapeutics Inc.
ELVN | NASDAQ
$47.90
-$0.97 (-1.98%)
Sep 22, 2026, 1:36 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -105.93M | -98.78M | -103.69M | -97.21M | -100.22M | -94.83M | -89.02M | -85.21M | -82.83M | -79.6M | -71.58M | -61.76M | -51.55M | -43.72M | -37.66M | -42.43M | -45.52M | -49.8M | -51.38M | -48.58M | -47.36M | -44.4M |
Depreciation & Amortization | 961K | 597K | 391K | 370K | 388K | 312K | 317K | 314K | 312K | 308K | 296K | 283K | 265K | 243K | 215K | 176K | 140K | 113K | 99K | 97K | 98K | 98K |
Stock-Based Compensation | 40.81M | 34.62M | 34.02M | 27.05M | 25.04M | 22.46M | 20.17M | 17.89M | 16.12M | 15.17M | 12.91M | 10.59M | 8.29M | 4.8M | 3.19M | 2.46M | 1.36M | 654K | n/a | 679K | 1.32M | 1.87M |
Other Working Capital | -3.68M | -2.14M | -1.94M | -3.16M | 1.03M | -1.28M | -5.35M | 1.91M | 1.6M | 5.8M | 3.65M | -2.19M | -7.08M | -8.09M | 27K | 334K | 2.34M | 4.12M | 125K | 1.51M | 780K | -741K |
Other Non-Cash Items | 3.63M | 157K | 104K | 974K | 1.91M | 504K | -118K | 1.28M | -1.2M | -707K | -125K | -2.59M | 910K | 1.74M | 1.74M | 2.77M | 2.05M | 3M | 4M | 3.15M | 2.08M | 1.12M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.17M | -4.17M | -4.17M | -4.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -6.41M | -2.06M | -1.12M | -2.85M | 2.3M | -2.4M | -4.54M | 1.43M | -403K | 5.22M | 1.4M | -3.46M | -5.4M | -5.63M | 438K | 611K | 1.11M | 1.92M | 514K | 2.1M | 1.86M | 423K |
Operating Cash Flow | -66.94M | -65.47M | -70.3M | -71.67M | -70.58M | -73.96M | -73.19M | -68.47M | -72.17M | -63.79M | -61.27M | -56.93M | -47.49M | -42.56M | -32.08M | -36.42M | -40.87M | -44.11M | -46.77M | -42.56M | -42M | -40.89M |
Capital Expenditures | -98K | -138K | -158K | -158K | -181K | -44K | -44K | -58K | -52K | -138K | -149K | -236K | -234K | -449K | -612K | -511K | -497K | -194K | -12K | -8K | -8K | -15K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -40M | -40M | -40M | -40M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -773.38M | -453.41M | -446.79M | -487.79M | -650.15M | -530.79M | -528.35M | -453.13M | -294.44M | -325.04M | -268.26M | -226.96M | -151.43M | n/a | n/a | -17.79M | -40.02M | -43.84M | -47.56M | -38.16M | -29.91M | -26.1M |
Sales Maturities Of Investments | 382.55M | 320.59M | 272.9M | 302.45M | 431.32M | 451.75M | 429.99M | 392.75M | 236.08M | 158.91M | 120M | 40M | n/a | n/a | n/a | 3.3M | 16.7M | 23.9M | 45.94M | 72.24M | 62.54M | 64.77M |
Other Investing Acitivies | 213K | 213K | 213K | n/a | 52.4M | 62.4M | 62.4M | 62.4M | 50M | 40M | 40M | 40M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -41.83M |
Investing Cash Flow | -390.72M | -132.74M | -173.84M | -185.49M | -166.61M | -16.69M | -36M | 1.96M | -48.41M | -166.27M | -148.41M | -187.2M | -151.66M | -449K | -612K | -15M | -23.82M | -20.13M | -1.63M | 34.07M | 32.62M | -3.18M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -10.05M | n/a | n/a | 90.48M | 90.48M | 90.48M | 90.75M | 270K | 270K | -1.05M | 73.09M | 70.71M | 70.71M | 72.02M | -2.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 473.73M | 228.69M | 218.87M | 258.22M | 259.7M | 43.13M | 133.17M | 93.28M | 91.74M | 87.12M | 234.29M | 231.82M | 232.41M | 235.23M | -1.8M | 568K | 47.4M | 49.05M | 49.1M | 49.71M | 2.85M | 10.79M |
Net Cash Flow | 16.07M | 30.48M | -25.28M | 1.06M | 22.51M | -47.51M | 23.98M | 26.83M | -28.79M | -142.88M | 12M | -24.97M | 45.95M | 206.29M | -9.44M | -25.8M | -17.6M | -16.96M | 611K | 41.14M | -6.61M | -33.28M |
Free Cash Flow | -67.04M | -65.6M | -70.46M | -71.82M | -70.76M | -74M | -73.24M | -68.53M | -72.22M | -63.92M | -61.42M | -57.17M | -47.72M | -43.01M | -32.69M | -36.93M | -41.37M | -44.31M | -46.78M | -42.56M | -42.01M | -40.91M |
Adj. Free Cash Flow | -107.85M | -100.22M | -104.48M | -98.87M | -95.8M | -96.46M | -93.41M | -86.42M | -88.34M | -79.09M | -74.33M | -67.76M | -56.01M | -47.81M | -35.88M | -39.38M | -42.72M | -44.96M | -46.78M | -43.24M | -43.33M | -42.78M |
Maintenance CapEx | -100K | -140K | -160K | -160K | -181K | -44K | -44K | -58K | -52K | -124K | -135K | -185K | -183K | -161K | -169K | -105K | -91K | -39K | -12K | -16K | -16K | -23K |
Growth CapEx | 2K | 2K | 2K | 2K | n/a | n/a | n/a | n/a | n/a | -14K | -14K | -51K | -51K | -288K | -443K | -406K | -406K | -155K | n/a | 8K | 8K | 8K |
Owner Earnings | -67.04M | -65.61M | -70.46M | -71.83M | -70.76M | -74M | -73.24M | -68.53M | -72.22M | -63.91M | -61.4M | -57.12M | -47.67M | -42.72M | -32.25M | -36.52M | -40.96M | -44.15M | -46.78M | -42.57M | -42.02M | -40.91M |
Add to Watchlist
Select watchlists to add or remove ELVN